• BML-277: A Causal Assay Map for Chk2 Biology

  2026-09-22

  BML-277 is a Chk2 inhibitor suited to separating direct kinase inhibition from downstream DNA damage phenotypes. This article presents a causal assay framework linking biochemical potency, T-cell radioprotection, and the nuclear cGAS–TRIM41 pathway without overstating what any single experiment can prove.

• Endothelial STING Rewires Tumor Vessel Immunity

  2026-09-21

  The reference study identifies endothelial STING as a major determinant of STING agonist–induced tumor vessel normalization and CD8+ T cell recruitment. Its central mechanistic advance is the finding that, after type I interferon receptor signaling, endothelial STING interacts with JAK1 and supports STAT activation through a palmitoylation-dependent mechanism that is distinct from canonical C-terminal-tail signaling.

• NHS-Biotin for Multimeric Protein Assay Design

  2026-09-21

  NHS-Biotin enables controlled labeling of multimeric proteins without confusing detection chemistry with the assembly mechanism. This guide connects N-hydroxysuccinimido biotin chemistry with peptidisc-assisted nanobody clustering to improve assay design, controls, and interpretation.

• Fluorescein TSA Fluorescence System Kit: Translation

  2026-09-20

  A mechanistic and strategic guide to using tyramide signal amplification for translational studies of diabetic retinal barrier dysfunction, with a focus on low-abundance targets, assay validation, and responsible interpretation.

• PA–Src–FAK–RhoA/ROCK Signaling in Decidualization

  2026-09-19

  The reference study identifies a phosphatidic acid–Src–FAK–RhoA/ROCK pathway that controls cytoskeletal remodeling during human endometrial stromal cell decidualization. Its combination of cell-based pathway perturbation and ovariectomized-mouse validation separates morphological differentiation from conventional decidual markers and highlights cytoskeletal signaling as a potential determinant of implantation competence.

• EdU Imaging Kits (Cy3): S-Phase Guide

  2026-09-18

  Learn how EdU Imaging Kits (Cy3), SKU K1075, support reproducible S-phase DNA synthesis measurement in microscopy and flow cytometry. This scenario-based guide covers assay design, CuAAC workflow choices, interpretation limits, and practical vendor selection.

• Phosbind Biotin for Context-Free Phosphoprotein Blots

  2026-09-18

  Phosbind Biotin enables sequence-independent protein phosphorylation analysis through dinuclear metal complex phosphate binding. This article connects the reagent to the PtrbZIP12 drought-response study and explains how to interpret phosphate-binding Western Blots alongside functional evidence.

• GlycoRNA–RBP Domains and TAT Peptide Entry

  2026-09-17

  The reference preprint presents evidence that cell-surface RNA-binding proteins and glycoRNAs organize into extracellular nanoclusters rather than existing as isolated surface components. These RNA-dependent domains provide interaction sites for the cell-penetrating peptide TAT, linking cell-surface molecular organization to peptide internalization and offering a framework for studying noncanonical surface proteomes.

• Doxorubicin Workflows for Senescence Assays

  2026-09-17

  Use Doxorubicin, also known as Adriamycin, as a controlled DNA-damage benchmark for apoptosis, senescence, and combination studies. This workflow pairs a practical anthracycline exposure design with the reference study’s Lactobacillus plantarum DS0037 nanovesicle model to distinguish broad cytotoxicity from senescent-cell-selective effects.

• Cucurbitacin I: A Systems Assay Strategy

  2026-09-16

  Cucurbitacin I and JSI-124 enable mechanism-resolved studies of STAT3 signaling, apoptosis, invasion, and tumor response. This article adds a systems-level assay perspective inspired by human SAN–cardiac plexus assembloids, while clearly separating evidence from cross-domain experimentation.

• Ultrasonic Implantable TTF: Mechanism and Findings

  2026-09-16

  The reference study presents a battery-free implantable Tumor Treating Field system powered by focused ultrasound and built around shape-engineered BaTiO3 pyramid receivers. Its improved acoustic-to-electric conversion, angular tolerance, and localized field delivery enabled glioblastoma growth suppression in vitro and reduced Ki-67 staining in a short pilot animal study.

• PSPro Enables All-at-Once Spatial Proteomics

  2026-09-15

  Mao and colleagues introduce PSPro, a proximity-labeling workflow that captures cell-type-associated proteomes directly from complex tissue slices. By combining antibody-guided biotinylation, affinity purification, and optional laser microdissection, the method profiles thousands of proteins while retaining cellular and spatial context.

• Roscovitine: Reliable Cell Assay Design

  2026-09-15

  This scenario-driven guide shows how Roscovitine (Seliciclib, CYC202), SKU A1723, can improve the interpretation and reproducibility of cell-cycle, viability, proliferation, and cytotoxicity experiments. It connects documented CDK potency and formulation data with practical controls, assay design, and responsible translational interpretation.

• PPP2R2A Loss Sensitizes HGSOC to CHK1 Inhibition

  2026-09-14

  The 2024 Theranostics study identifies low PPP2R2A, encoding the PP2A B55α regulatory subunit, as a potential biomarker of CHK1 inhibitor sensitivity in high-grade serous ovarian cancer. Its experiments connect PPP2R2A deficiency with excessive replication initiation, c-Myc-associated replication stress, and dependence on CHK1, including in models resistant to PARP inhibition.

• Stattic Workflows for STAT3-Driven Cancer Research

  2026-09-14

  Build a practical Stattic workflow for STAT3 pathway validation, apoptosis induction in cancer cells, and radiation-response studies. This guide connects concentration planning, orthogonal readouts, assay controls, and troubleshooting for head and neck squamous cell carcinoma (HNSCC) research.

8003 records 1/534 page Next 12345 下5页 Last page